{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:56:10Z","timestamp":1788544570857,"version":"build-2803163510"},"reference-count":159,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012352","name":"Universit\u00e0 degli Studi di Milano","doi-asserted-by":"publisher","award":["PSR 2021 linea 2 azione A"],"award-info":[{"award-number":["PSR 2021 linea 2 azione A"]}],"id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012352","name":"Universit\u00e0 degli Studi di Milano","doi-asserted-by":"publisher","award":["PSR 2022 Linea 2 Azione A"],"award-info":[{"award-number":["PSR 2022 Linea 2 Azione A"]}],"id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012352","name":"Universit\u00e0 degli Studi di Milano","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic kidney disease (CKD) is expected to be the fifth cause of global mortality by 2040. Modifiable and non-modifiable risk factors for CKD range from metabolic conditions, such as diabetes or obesity, to genetic defects. Regardless of the triggering factor, irreversible injury and loss of kidney cells result in the decline of kidney function. Renal damage often occurs through common signaling pathways promoting inflammation, oxidative stress, organelle dysfunction, complement activation, apoptosis, and fibrogenesis. Lipotoxicity is emerging as a key player in CKD of both metabolic and non-metabolic origin. Here, we provide an overview of the mechanisms beyond renal lipid accumulation in CKD, ranging from systemic imbalance of lipid\/lipoprotein metabolism to alterations of cell lipid uptake, synthesis, and disposal. Moreover, the impact of lipid accumulation in glomerular and tubular cells is addressed. Several lipid species were shown to accumulate in renal cells, from cholesterol and fatty acids to sphingolipids; they can affect cell viability and function not only as structural components of biological membranes or energetic substrates but also as bioactive molecules able to modulate multiple signaling pathways. The possible role of established and novel approaches to correct systemic or local lipid imbalance in the management of CKD is discussed.<\/jats:p>","DOI":"10.1007\/s00109-026-02654-0","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T01:33:27Z","timestamp":1771551207000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Lipids in kidney diseases: from systemic imbalance to intrarenal alterations of cellular lipid metabolism in rare and common kidney diseases"],"prefix":"10.1007","volume":"104","author":[{"given":"Carola","family":"Garavaglia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Ossoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3082-2120","authenticated-orcid":false,"given":"Monica","family":"Gomaraschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"2654_CR1","doi-asserted-by":"publisher","unstructured":"Miguel V, Shaw IW, Kramann R (2025) Metabolism at the crossroads of inflammation and fibrosis in chronic kidney disease. Nat Rev Nephrol 21(1):39\u201356.\u00a0https:\/\/doi.org\/10.1038\/s41581-024-00889-z","DOI":"10.1038\/s41581-024-00889-z"},{"key":"2654_CR2","doi-asserted-by":"publisher","unstructured":"Bobulescu IA (2010) Renal lipid metabolism and lipotoxicity. Curr Opin Nephrol Hypertens 19(4):393\u2013402.\u00a0https:\/\/doi.org\/10.1097\/MNH.0b013e32833aa4ac","DOI":"10.1097\/MNH.0b013e32833aa4ac"},{"key":"2654_CR3","doi-asserted-by":"publisher","unstructured":"Su H, Wan C, Lei CT, Zhang CY, Ye C, Tang H, Qiu Y, Zhang C (2018) Lipid deposition in kidney diseases: interplay among redox, lipid mediators, and renal impairment. Antioxid Redox Signal 28(10):1027\u20131043.\u00a0https:\/\/doi.org\/10.1089\/ars.2017.7066","DOI":"10.1089\/ars.2017.7066"},{"key":"2654_CR4","doi-asserted-by":"publisher","unstructured":"Mitrofanova A, Merscher S, Fornoni A (2023) Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease. Nat Rev Nephrol 19(10):629\u2013645.\u00a0https:\/\/doi.org\/10.1038\/s41581-023-00741-w","DOI":"10.1038\/s41581-023-00741-w"},{"key":"2654_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21072632","author":"L Opazo-Rios","year":"2020","unstructured":"Opazo-Rios L, Mas S, Marin-Royo G, Mezzano S, Gomez-Guerrero C, Moreno JA, Egido J (2020) Lipotoxicity and diabetic nephropathy: novel mechanistic insights and therapeutic opportunities. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21072632","journal-title":"Int J Mol Sci"},{"key":"2654_CR6","doi-asserted-by":"publisher","unstructured":"Bhargava P, Schnellmann RG (2017) Mitochondrial energetics in the kidney. Nat Rev Nephrol 13(10):629\u2013646.\u00a0https:\/\/doi.org\/10.1038\/nrneph.2017.107","DOI":"10.1038\/nrneph.2017.107"},{"key":"2654_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/nu13051580","author":"LS Gewin","year":"2021","unstructured":"Gewin LS (2021) Sugar or fat? Renal tubular metabolism reviewed in health and disease. Nutrients. https:\/\/doi.org\/10.3390\/nu13051580","journal-title":"Nutrients"},{"key":"2654_CR8","doi-asserted-by":"publisher","unstructured":"Ouali F, Djouadi F, Merlet-Benichou C, Bastin J (1998) Dietary lipids regulate beta-oxidation enzyme gene expression in the developing rat kidney. Am J Physiol-Renal Physiol 275(5):F777-784.\u00a0https:\/\/doi.org\/10.1152\/ajprenal.1998.275.5.F777","DOI":"10.1152\/ajprenal.1998.275.5.F777"},{"key":"2654_CR9","doi-asserted-by":"publisher","unstructured":"Tovar-Palacio C, Torres N, Diaz-Villasenor A, Tovar AR (2012) The role of nuclear receptors in the kidney in obesity and metabolic syndrome. Genes Nutr 7(4):483\u2013498.\u00a0https:\/\/doi.org\/10.1007\/s12263-012-0295-5","DOI":"10.1007\/s12263-012-0295-5"},{"key":"2654_CR10","doi-asserted-by":"publisher","unstructured":"Yokoi H, Yanagita M (2016) Targeting the fatty acid transport protein CD36, a class B scavenger receptor, in the treatment of renal disease. Kidney Int 89(4):740\u2013742.\u00a0https:\/\/doi.org\/10.1016\/j.kint.2016.01.009","DOI":"10.1016\/j.kint.2016.01.009"},{"key":"2654_CR11","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.136845","author":"S Khan","year":"2020","unstructured":"Khan S, Gaivin R, Abramovich C, Boylan M, Calles J, Schelling JR (2020) Fatty acid transport protein-2 regulates glycemic control and diabetic kidney disease progression. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.136845","journal-title":"JCI Insight"},{"key":"2654_CR12","doi-asserted-by":"publisher","unstructured":"Decleves AE, Zolkipli Z, Satriano J, Wang L, Nakayama T, Rogac M, Le TP, Nortier JL, Farquhar MG, Naviaux RK, Sharma K (2014) Regulation of lipid accumulation by AMP-activated kinase [corrected] in high fat diet-induced kidney injury. Kidney Int 85(3):611\u2013623.\u00a0https:\/\/doi.org\/10.1038\/ki.2013.462","DOI":"10.1038\/ki.2013.462"},{"key":"2654_CR13","doi-asserted-by":"publisher","unstructured":"Herman-Edelstein M, Scherzer P, Tobar A, Levi M, Gafter U (2014) Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy. J Lipid Res 55(3):561\u2013572.\u00a0https:\/\/doi.org\/10.1194\/jlr.P040501","DOI":"10.1194\/jlr.P040501"},{"key":"2654_CR14","doi-asserted-by":"publisher","unstructured":"Hartleben B, Godel M, Meyer-Schwesinger C, Liu S, Ulrich T, Kobler S, Wiech T, Grahammer F, Arnold SJ, Lindenmeyer MT, Cohen CD, Pavenstadt H, Kerjaschki D, Mizushima N, Shaw AS, Walz G, Huber TB (2010) Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J Clin Invest 120(4):1084\u20131096.\u00a0https:\/\/doi.org\/10.1172\/JCI39492","DOI":"10.1172\/JCI39492"},{"key":"2654_CR15","doi-asserted-by":"publisher","unstructured":"Merscher S, Fornoni A (2014) Podocyte pathology and nephropathy - sphingolipids in glomerular diseases. Front Endocrinol (Lausanne) 5:127.\u00a0https:\/\/doi.org\/10.3389\/fendo.2014.00127","DOI":"10.3389\/fendo.2014.00127"},{"issue":"1","key":"2654_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145946","volume":"11","author":"B Martin-Fernandez","year":"2016","unstructured":"Martin-Fernandez B, Rubio-Navarro A, Cortegano I, Ballesteros S, Alia M, Cannata-Ortiz P, Olivares-Alvaro E, Egido J, de Andres B, Gaspar ML, de Las Heras N, Lahera V, Moreno JA (2016) Aldosterone induces renal fibrosis and inflammatory M1-macrophage subtype via mineralocorticoid receptor in rats. PLoS One 11(1):e0145946. https:\/\/doi.org\/10.1371\/journal.pone.0145946","journal-title":"PLoS One"},{"key":"2654_CR17","doi-asserted-by":"publisher","unstructured":"Srivastava SP, Zhou H, Setia O, Dardik A, Fernandez-Hernando C, Goodwin J (2021) Podocyte glucocorticoid receptors are essential for glomerular endothelial cell homeostasis in diabetes mellitus. J Am Heart Assoc 10(15):e019437.\u00a0https:\/\/doi.org\/10.1161\/JAHA.120.019437","DOI":"10.1161\/JAHA.120.019437"},{"key":"2654_CR18","doi-asserted-by":"publisher","unstructured":"Ito A, Hong C, Rong X, Zhu X, Tarling EJ, Hedde PN, Gratton E, Parks J, Tontonoz P (2015) LXrs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling. Elife 4:e08009.\u00a0https:\/\/doi.org\/10.7554\/eLife.08009","DOI":"10.7554\/eLife.08009"},{"key":"2654_CR19","doi-asserted-by":"publisher","unstructured":"Luo J, Yang H, Song BL (2020) Mechanisms and regulation of cholesterol homeostasis. Nat Rev Mol Cell Biol 21(4):225\u2013245. https:\/\/doi.org\/10.1038\/s41580-019-0190-7","DOI":"10.1038\/s41580-019-0190-7"},{"key":"2654_CR20","doi-asserted-by":"publisher","unstructured":"Pan X (2022) Cholesterol metabolism in chronic kidney disease: physiology, pathologic mechanisms, and treatment. Adv Exp Med Biol 1372:119\u2013143.\u00a0https:\/\/doi.org\/10.1007\/978-981-19-0394-6_9","DOI":"10.1007\/978-981-19-0394-6_9"},{"key":"2654_CR21","doi-asserted-by":"publisher","unstructured":"Liu X, Ducasa GM, Mallela SK, Kim JJ, Molina J, Mitrofanova A, Wilbon SS, Ge M, Fontanella A, Pedigo C, Santos JV, Nelson RG, Drexler Y, Contreras G, Al-Ali H, Merscher S, Fornoni A (2020) Sterol-O-acyltransferase-1 has a role in kidney disease associated with diabetes and Alport syndrome. Kidney Int 98(5):1275\u20131285.\u00a0https:\/\/doi.org\/10.1016\/j.kint.2020.06.040","DOI":"10.1016\/j.kint.2020.06.040"},{"key":"2654_CR22","doi-asserted-by":"publisher","unstructured":"Wahl P, Ducasa GM, Fornoni A (2016) Systemic and renal lipids in kidney disease development and progression. Am J Physiol Renal Physiol 310(6):F433-445.\u00a0https:\/\/doi.org\/10.1152\/ajprenal.00375.2015","DOI":"10.1152\/ajprenal.00375.2015"},{"key":"2654_CR23","doi-asserted-by":"publisher","unstructured":"Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, Pletcher MA, Smith AE, Tang K, Yuan CW, Brown JC, Friedman J, He J, Heuton KR, Holmberg M, Patel DJ, Reidy P, Carter A, Cercy K, Chapin A, Douwes-Schultz D, Frank T, Goettsch F, Liu PY, Nandakumar V, Reitsma MB, Reuter V, Sadat N, Sorensen RJD, Srinivasan V, Updike RL, York H, Lopez AD, Lozano R, Lim SS, Mokdad AH, Vollset SE, Murray CJL (2018) Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet 392(10159):2052\u20132090. https:\/\/doi.org\/10.1016\/S0140-6736(18)31694-5","DOI":"10.1016\/S0140-6736(18)31694-5"},{"issue":"1","key":"2654_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-024-00589-9","volume":"11","author":"P Romagnani","year":"2025","unstructured":"Romagnani P, Agarwal R, Chan JCN, Levin A, Kalyesubula R, Karam S, Nangaku M, Rodriguez-Iturbe B, Anders HJ (2025) Chronic kidney disease. Nat Rev Dis Primers 11(1):8. https:\/\/doi.org\/10.1038\/s41572-024-00589-9","journal-title":"Nat Rev Dis Primers"},{"key":"2654_CR25","doi-asserted-by":"publisher","unstructured":"Djudjaj S, Boor P (2019) Cellular and molecular mechanisms of kidney fibrosis. Mol Aspects Med 65:16\u201336.\u00a0https:\/\/doi.org\/10.1016\/j.mam.2018.06.002","DOI":"10.1016\/j.mam.2018.06.002"},{"key":"2654_CR26","doi-asserted-by":"publisher","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351(13):1296\u20131305.\u00a0https:\/\/doi.org\/10.1056\/NEJMoa041031","DOI":"10.1056\/NEJMoa041031"},{"issue":"5","key":"2654_CR27","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1161\/HYPERTENSIONAHA.122.20354","volume":"80","author":"CE Douglas","year":"2023","unstructured":"Douglas CE, Roem J, Flynn JT, Furth SL, Warady BA, Halbach SM, chronic kidney disease in children study I (2023) Effect of age on hypertension recognition in children with chronic kidney disease: a report from the chronic kidney disease in children study. Hypertension 80(5):1048\u20131056. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.122.20354","journal-title":"Hypertension"},{"key":"2654_CR28","doi-asserted-by":"publisher","unstructured":"Palmer BF, Clegg DJ (2024) Hyperkalemia treatment standard. Nephrol Dial Transplant 39(7):1097\u20131104.\u00a0https:\/\/doi.org\/10.1093\/ndt\/gfae056","DOI":"10.1093\/ndt\/gfae056"},{"key":"2654_CR29","doi-asserted-by":"publisher","unstructured":"Raphael KL (2018) Metabolic acidosis and subclinical metabolic acidosis in CKD. J Am Soc Nephrol 29(2):376\u2013382.\u00a0https:\/\/doi.org\/10.1681\/ASN.2017040422","DOI":"10.1681\/ASN.2017040422"},{"key":"2654_CR30","doi-asserted-by":"publisher","unstructured":"Steiger S, Rossaint J, Zarbock A, Anders HJ (2022) Secondary immunodeficiency related to kidney disease (SIDKD)-definition, unmet need, and mechanisms. J Am Soc Nephrol 33(2):259\u2013278.\u00a0https:\/\/doi.org\/10.1681\/ASN.2021091257","DOI":"10.1681\/ASN.2021091257"},{"key":"2654_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107146","volume":"203","author":"M Barbieri","year":"2024","unstructured":"Barbieri M, Chiodini P, Di Gennaro P, Hafez G, Liabeuf S, Malyszko J, Mani LY, Mattace-Raso F, Pepin M, Perico N, Simeoni M, Zoccali C, Tortorella G, Capuano A, Remuzzi G, Capasso G, Paolisso G, collaborators CA (2024) Efficacy of erythropoietin as a neuroprotective agent in CKD-associated cognitive dysfunction: a literature systematic review. Pharmacol Res 203:107146. https:\/\/doi.org\/10.1016\/j.phrs.2024.107146","journal-title":"Pharmacol Res"},{"key":"2654_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/cells10040764","author":"A Strazzella","year":"2021","unstructured":"Strazzella A, Ossoli A, Calabresi L (2021) High-density lipoproteins and the kidney. Cells. https:\/\/doi.org\/10.3390\/cells10040764","journal-title":"Cells"},{"key":"2654_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/cells11203236","author":"JR Schelling","year":"2022","unstructured":"Schelling JR (2022) The contribution of lipotoxicity to diabetic kidney disease. Cells. https:\/\/doi.org\/10.3390\/cells11203236","journal-title":"Cells"},{"key":"2654_CR34","doi-asserted-by":"publisher","unstructured":"Ginsberg HN, Packard CJ, Chapman MJ, Boren J, Aguilar-Salinas CA, Averna M, Ference BA, Gaudet D, Hegele RA, Kersten S, Lewis GF, Lichtenstein AH, Moulin P, Nordestgaard BG, Remaley AT, Staels B, Stroes ESG, Taskinen MR, Tokgozoglu LS, Tybjaerg-Hansen A, Stock JK, Catapano AL (2021) Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society. Eur Heart J 42(47):4791\u20134806.\u00a0https:\/\/doi.org\/10.1093\/eurheartj\/ehab551","DOI":"10.1093\/eurheartj\/ehab551"},{"issue":"4","key":"2654_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-021-01455-w","volume":"23","author":"E Bahiru","year":"2021","unstructured":"Bahiru E, Hsiao R, Phillipson D, Watson KE (2021) Mechanisms and treatment of dyslipidemia in diabetes. Curr Cardiol Rep 23(4):26. https:\/\/doi.org\/10.1007\/s11886-021-01455-w","journal-title":"Curr Cardiol Rep"},{"key":"2654_CR36","doi-asserted-by":"publisher","unstructured":"Riedel MJ, Light PE (2005) Saturated and cis\/trans unsaturated acyl CoA esters differentially regulate wild-type and polymorphic beta-cell ATP-sensitive K+ channels. Diabetes 54(7):2070\u20132079.\u00a0https:\/\/doi.org\/10.2337\/diabetes.54.7.2070","DOI":"10.2337\/diabetes.54.7.2070"},{"key":"2654_CR37","doi-asserted-by":"publisher","unstructured":"Riedel MJ, Baczko I, Searle GJ, Webster N, Fercho M, Jones L, Lang J, Lytton J, Dyck JR, Light PE (2006) Metabolic regulation of sodium-calcium exchange by intracellular acyl CoAs. EMBO J 25(19):4605\u20134614.\u00a0https:\/\/doi.org\/10.1038\/sj.emboj.7601321","DOI":"10.1038\/sj.emboj.7601321"},{"key":"2654_CR38","doi-asserted-by":"publisher","unstructured":"Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YD (1988) Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 37(8):1020\u20131024.\u00a0https:\/\/doi.org\/10.2337\/diab.37.8.1020","DOI":"10.2337\/diab.37.8.1020"},{"key":"2654_CR39","doi-asserted-by":"publisher","unstructured":"Afshinnia F, Rajendiran TM, Soni T, Byun J, Wernisch S, Sas KM, Hawkins J, Bellovich K, Gipson D, Michailidis G, Pennathur S, Michigan Kidney Translational Core CIG (2018) Impaired beta-oxidation and altered complex lipid fatty acid partitioning with advancing CKD. J Am Soc Nephrol 29(1):295\u2013306.\u00a0https:\/\/doi.org\/10.1681\/ASN.2017030350","DOI":"10.1681\/ASN.2017030350"},{"key":"2654_CR40","doi-asserted-by":"publisher","unstructured":"Aflaki E, Radovic B, Chandak PG, Kolb D, Eisenberg T, Ring J, Fertschai I, Uellen A, Wolinski H, Kohlwein SD, Zechner R, Levak-Frank S, Sattler W, Graier WF, Malli R, Madeo F, Kratky D (2011) Triacylglycerol accumulation activates the mitochondrial apoptosis pathway in macrophages. J Biol Chem 286(9):7418\u20137428.\u00a0https:\/\/doi.org\/10.1074\/jbc.M110.175703","DOI":"10.1074\/jbc.M110.175703"},{"key":"2654_CR41","doi-asserted-by":"publisher","unstructured":"Santamarina-Fojo S, Hoeg JM, Assmann G, Brewer HB (2001) Lecithin cholesterol acyltransferase deficiency and fish eye disease. The metabolic and molecular bases of inherited diseases. McGraw-Hill:New York. NY, USA 2001:2817\u20132833. https:\/\/doi.org\/10.1036\/ommbid.147","DOI":"10.1036\/ommbid.147"},{"issue":"1","key":"2654_CR42","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2011.01.025","volume":"216","author":"AG Holleboom","year":"2011","unstructured":"Holleboom AG, Kuivenhoven JA, van Olden CC, Peter J, Schimmel AW, Levels JH, Valentijn RM, Vos P, Defesche JC, Kastelein JJ, Hovingh GK, Stroes ES, Hollak CE (2011) Proteinuria in early childhood due to familial LCAT deficiency caused by loss of a disulfide bond in lecithin:cholesterol acyl transferase. Atherosclerosis 216(1):161\u2013165. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.01.025","journal-title":"Atherosclerosis"},{"key":"2654_CR43","doi-asserted-by":"publisher","unstructured":"Pavanello C, Ossoli A, Arca M, D\u2019Erasmo L, Boscutti G, Gesualdo L, Lucchi T, Sampietro T, Veglia F, Calabresi L (2020) Progression of chronic kidney disease in familial LCAT deficiency: a follow-up of the Italian cohort. J Lipid Res 61(12):1784\u20131788.\u00a0https:\/\/doi.org\/10.1194\/jlr.P120000976","DOI":"10.1194\/jlr.P120000976"},{"issue":"9","key":"2654_CR44","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1161\/01.ATV.0000175751.30616.13","volume":"25","author":"L Calabresi","year":"2005","unstructured":"Calabresi L, Pisciotta L, Costantin A, Frigerio I, Eberini I, Alessandrini P, Arca M, Bon GB, Boscutti G, Busnach G, Frasca G, Gesualdo L, Gigante M, Lupattelli G, Montali A, Pizzolitto S, Rabbone I, Rolleri M, Ruotolo G, Sampietro T, Sessa A, Vaudo G, Cantafora A, Veglia F, Calandra S, Bertolini S, Franceschini G (2005) The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families. Arterioscler Thromb Vasc Biol 25(9):1972\u20131978. https:\/\/doi.org\/10.1161\/01.ATV.0000175751.30616.13","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"2654_CR45","first-page":"369","volume":"28","author":"G Boscutti","year":"2011","unstructured":"Boscutti G, Calabresi L, Pizzolitto S, Boer E, Bosco M, Mattei PL, Martone M, Milutinovic N, Berbecar D, Beltram E, Franceschini G (2011) [LCAT deficiency: a nephrological diagnosis]. G Ital Nefrol 28(4):369\u2013382","journal-title":"G Ital Nefrol"},{"issue":"204","key":"2654_CR46","first-page":"411","volume":"51","author":"LK Borysiewicz","year":"1982","unstructured":"Borysiewicz LK, Soutar AK, Evans DJ, Thompson GR, Rees AJ (1982) Renal failure in familial lecithin: cholesterol acyltransferase deficiency. Q J Med 51(204):411\u2013426","journal-title":"Q J Med"},{"key":"2654_CR47","doi-asserted-by":"publisher","unstructured":"Imbasciati E, Paties C, Scarpioni L, Mihatsch MJ (1986) Renal lesions in familial lecithin-cholesterol acyltransferase deficiency. Ultrastructural heterogeneity of glomerular changes. Am J Nephrol 6(1):66\u201370.\u00a0https:\/\/doi.org\/10.1159\/000167056","DOI":"10.1159\/000167056"},{"issue":"2","key":"2654_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150083","volume":"11","author":"A Ossoli","year":"2016","unstructured":"Ossoli A, Neufeld EB, Thacker SG, Vaisman B, Pryor M, Freeman LA, Brantner CA, Baranova I, Francone NO, Demosky SJ Jr., Vitali C, Locatelli M, Abbate M, Zoja C, Franceschini G, Calabresi L, Remaley AT (2016) Lipoprotein X causes renal disease in LCAT deficiency. PLoS One 11(2):e0150083. https:\/\/doi.org\/10.1371\/journal.pone.0150083","journal-title":"PLoS One"},{"key":"2654_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12081498","author":"M Gomaraschi","year":"2023","unstructured":"Gomaraschi M, Turri M, Strazzella A, Lhomme M, Pavanello C, Le Goff W, Kontush A, Calabresi L, Ossoli A (2023) Abnormal lipoproteins trigger oxidative stress-mediated apoptosis of renal cells in LCAT deficiency. Antioxidants. https:\/\/doi.org\/10.3390\/antiox12081498","journal-title":"Antioxidants"},{"key":"2654_CR50","doi-asserted-by":"publisher","unstructured":"Gilbert MA, Bauer RC, Rajagopalan R, Grochowski CM, Chao G, McEldrew D, Nassur JA, Rand EB, Krock BL, Kamath BM, Krantz ID, Piccoli DA, Loomes KM, Spinner NB (2019) Alagille syndrome mutation update: comprehensive overview of JAG1 and NOTCH2 mutation frequencies and insight into missense variant classification. Hum Mutat 40(12):2197\u20132220.\u00a0https:\/\/doi.org\/10.1002\/humu.23879","DOI":"10.1002\/humu.23879"},{"key":"2654_CR51","doi-asserted-by":"publisher","unstructured":"Habib R, Dommergues JP, Gubler MC, Hadchouel M, Gautier M, Odievre M, Alagille D (1987) Glomerular mesangiolipidosis in Alagille syndrome (arteriohepatic dysplasia). Pediatr Nephrol 1(3):455\u2013464.\u00a0https:\/\/doi.org\/10.1007\/BF00849254","DOI":"10.1007\/BF00849254"},{"key":"2654_CR52","doi-asserted-by":"publisher","unstructured":"Davis J, Griffiths R, Larkin K, Rozansky D, Troxell M (2010) Glomerular basement membrane lipidosis in Alagille syndrome. Pediatr Nephrol 25(6):1181\u20131184.\u00a0https:\/\/doi.org\/10.1007\/s00467-009-1426-0","DOI":"10.1007\/s00467-009-1426-0"},{"key":"2654_CR53","doi-asserted-by":"publisher","unstructured":"Ayoub MD, Kamath BM (2022) Alagille syndrome: current understanding of pathogenesis, and challenges in diagnosis and management. Clin Liver Dis 26(3):355\u2013370.\u00a0https:\/\/doi.org\/10.1016\/j.cld.2022.03.002","DOI":"10.1016\/j.cld.2022.03.002"},{"key":"2654_CR54","doi-asserted-by":"publisher","unstructured":"Saito T, Matsunaga A, Fukunaga M, Nagahama K, Hara S, Muso E (2020) Apolipoprotein E-related glomerular disorders. Kidney Int 97(2):279\u2013288.\u00a0https:\/\/doi.org\/10.1016\/j.kint.2019.10.031","DOI":"10.1016\/j.kint.2019.10.031"},{"key":"2654_CR55","doi-asserted-by":"publisher","unstructured":"Matsunaga A, Saito T (2025) Impact of apolipoprotein E variants: a review of naturally occurring variants and clinical features. J Atheroscler Thromb 32(3):281\u2013303.\u00a0https:\/\/doi.org\/10.5551\/jat.65393","DOI":"10.5551\/jat.65393"},{"key":"2654_CR56","doi-asserted-by":"publisher","unstructured":"Kawanishi K, Sawada A, Ochi A, Moriyama T, Mitobe M, Mochizuki T, Honda K, Oda H, Nishikawa T, Nitta K (2013) Glomerulopathy with homozygous apolipoprotein e2: a report of three cases and review of the literature. Case Rep Nephrol Urol 3(2):128\u2013135.\u00a0https:\/\/doi.org\/10.1159\/000356849","DOI":"10.1159\/000356849"},{"key":"2654_CR57","doi-asserted-by":"publisher","unstructured":"Katsarou M, Stratikos E, Chroni A (2018) Thermodynamic destabilization and aggregation propensity as the mechanism behind the association of apoE3 mutants and lipoprotein glomerulopathy. J Lipid Res 59(12):2339\u20132348.\u00a0https:\/\/doi.org\/10.1194\/jlr.M088732","DOI":"10.1194\/jlr.M088732"},{"key":"2654_CR58","doi-asserted-by":"publisher","unstructured":"Saito T, Matsunaga A, Ito K, Nakashima H (2014) Topics in lipoprotein glomerulopathy: an overview. Clin Exp Nephrol 18(2):214\u2013217.\u00a0https:\/\/doi.org\/10.1007\/s10157-013-0887-4","DOI":"10.1007\/s10157-013-0887-4"},{"key":"2654_CR59","doi-asserted-by":"publisher","unstructured":"Saito T, Matsunaga A, Oikawa S (2006) Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases. Am J Kidney Dis 47(2):199\u2013211.\u00a0https:\/\/doi.org\/10.1053\/j.ajkd.2005.10.017","DOI":"10.1053\/j.ajkd.2005.10.017"},{"key":"2654_CR60","doi-asserted-by":"publisher","unstructured":"Li MS, Li Y, Liu Y, Zhou XJ, Zhang H (2022) An updated review and meta analysis of lipoprotein glomerulopathy. Front Med (Lausanne) 9:905007.\u00a0https:\/\/doi.org\/10.3389\/fmed.2022.905007","DOI":"10.3389\/fmed.2022.905007"},{"key":"2654_CR61","doi-asserted-by":"publisher","unstructured":"Woroniecka KI, Park AS, Mohtat D, Thomas DB, Pullman JM, Susztak K (2011) Transcriptome analysis of human diabetic kidney disease. Diabetes 60(9):2354\u20132369.\u00a0https:\/\/doi.org\/10.2337\/db10-1181","DOI":"10.2337\/db10-1181"},{"key":"2654_CR62","doi-asserted-by":"publisher","unstructured":"Sun H, Yuan Y, Sun ZL (2013) Cholesterol contributes to diabetic nephropathy through SCAP-SREBP-2 pathway. Int J Endocrinol 2013:592576.\u00a0https:\/\/doi.org\/10.1155\/2013\/592576","DOI":"10.1155\/2013\/592576"},{"key":"2654_CR63","doi-asserted-by":"publisher","unstructured":"Ducasa GM, Mitrofanova A, Mallela SK, Liu X, Molina J, Sloan A, Pedigo CE, Ge M, Santos JV, Hernandez Y, Kim JJ, Maugeais C, Mendez AJ, Nair V, Kretzler M, Burke GW, Nelson RG, Ishimoto Y, Inagi R, Banerjee S, Liu S, Szeto HH, Merscher S, Fontanesi F, Fornoni A (2019) ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytes. J Clin Invest 129(8):3387\u20133400.\u00a0https:\/\/doi.org\/10.1172\/JCI125316","DOI":"10.1172\/JCI125316"},{"key":"2654_CR64","doi-asserted-by":"publisher","unstructured":"Mitrofanova A, Molina J, Varona Santos J, Guzman J, Morales XA, Ducasa GM, Bryn J, Sloan A, Volosenco I, Kim JJ, Ge M, Mallela SK, Kretzler M, Eddy S, Martini S, Wahl P, Pastori S, Mendez AJ, Burke GW, Merscher S, Fornoni A (2018) Hydroxypropyl-beta-cyclodextrin protects from kidney disease in experimental Alport syndrome and focal segmental glomerulosclerosis. Kidney Int 94(6):1151\u20131159.\u00a0https:\/\/doi.org\/10.1016\/j.kint.2018.06.031","DOI":"10.1016\/j.kint.2018.06.031"},{"key":"2654_CR65","doi-asserted-by":"publisher","unstructured":"Kang HM, Ahn SH, Choi P, Ko YA, Han SH, Chinga F, Park AS, Tao J, Sharma K, Pullman J, Bottinger EP, Goldberg IJ, Susztak K (2015) Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat Med 21(1):37\u201346.\u00a0https:\/\/doi.org\/10.1038\/nm.3762","DOI":"10.1038\/nm.3762"},{"issue":"2","key":"2654_CR66","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cmet.2020.11.011","volume":"33","author":"P Dhillon","year":"2021","unstructured":"Dhillon P, Park J, Hurtado Del Pozo C, Li L, Doke T, Huang S, Zhao J, Kang HM, Shrestra R, Balzer MS, Chatterjee S, Prado P, Han SY, Liu H, Sheng X, Dierickx P, Batmanov K, Romero JP, Prosper F, Li M, Pei L, Kim J, Montserrat N, Susztak K (2021) The nuclear receptor ESRRA protects from kidney disease by coupling metabolism and differentiation. Cell Metab 33(2):379-394 e378. https:\/\/doi.org\/10.1016\/j.cmet.2020.11.011","journal-title":"Cell Metab"},{"key":"2654_CR67","doi-asserted-by":"publisher","unstructured":"Dif N, Euthine V, Gonnet E, Laville M, Vidal H, Lefai E (2006) Insulin activates human sterol-regulatory-element-binding protein-1c (SREBP-1c) promoter through SRE motifs. Biochem J 400(1):179\u2013188.\u00a0https:\/\/doi.org\/10.1042\/BJ20060499","DOI":"10.1042\/BJ20060499"},{"key":"2654_CR68","doi-asserted-by":"publisher","unstructured":"Prinz WA (2014) Bridging the gap: membrane contact sites in signaling, metabolism, and organelle dynamics. J Cell Biol 205(6):759\u2013769.\u00a0https:\/\/doi.org\/10.1083\/jcb.201401126","DOI":"10.1083\/jcb.201401126"},{"key":"2654_CR69","doi-asserted-by":"publisher","unstructured":"Ren L, Cui H, Wang Y, Ju F, Cai Y, Gang X, Wang G (2023) The role of lipotoxicity in kidney disease: from molecular mechanisms to therapeutic prospects. Biomed Pharmacother 161:114465.\u00a0https:\/\/doi.org\/10.1016\/j.biopha.2023.114465","DOI":"10.1016\/j.biopha.2023.114465"},{"key":"2654_CR70","doi-asserted-by":"publisher","unstructured":"Lakhia R, Yheskel M, Flaten A, Quittner-Strom EB, Holland WL, Patel V (2018) Pparalpha agonist fenofibrate enhances fatty acid beta-oxidation and attenuates polycystic kidney and liver disease in mice. Am J Physiol Renal Physiol 314(1):F122\u2013F131.\u00a0https:\/\/doi.org\/10.1152\/ajprenal.00352.2017","DOI":"10.1152\/ajprenal.00352.2017"},{"key":"2654_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137173","author":"X Song","year":"2024","unstructured":"Song X, Pickel L, Sung HK, Scholey J, Pei Y (2024) Reprogramming of energy metabolism in human PKD1 polycystic kidney disease: a systems biology analysis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25137173","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2654_CR72","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/path.5150","volume":"246","author":"E Rampanelli","year":"2018","unstructured":"Rampanelli E, Ochodnicky P, Vissers JP, Butter LM, Claessen N, Calcagni A, Kors L, Gethings LA, Bakker SJ, de Borst MH, Navis GJ, Liebisch G, Speijer D, van den Bergh Weerman MA, Jung B, Aten J, Steenbergen E, Schmitz G, Ballabio A, Florquin S, Aerts JM, Leemans JC (2018) Excessive dietary lipid intake provokes an acquired form of lysosomal lipid storage disease in the kidney. J Pathol 246(4):470\u2013484. https:\/\/doi.org\/10.1002\/path.5150","journal-title":"J Pathol"},{"key":"2654_CR73","doi-asserted-by":"publisher","unstructured":"Sieber J, Lindenmeyer MT, Kampe K, Campbell KN, Cohen CD, Hopfer H, Mundel P, Jehle AW (2010) Regulation of podocyte survival and endoplasmic reticulum stress by fatty acids. Am J Physiol Renal Physiol 299(4):F821-829.\u00a0https:\/\/doi.org\/10.1152\/ajprenal.00196.2010","DOI":"10.1152\/ajprenal.00196.2010"},{"key":"2654_CR74","doi-asserted-by":"publisher","unstructured":"Liu G, Han F, Yang Y, Xie Y, Jiang H, Mao Y, Wang H, Wang M, Chen R, Yang J, Chen J (2011) Evaluation of sphingolipid metabolism in renal cortex of rats with streptozotocin-induced diabetes and the effects of rapamycin. Nephrol Dial Transplant 26(5):1493\u20131502.\u00a0https:\/\/doi.org\/10.1093\/ndt\/gfq633","DOI":"10.1093\/ndt\/gfq633"},{"key":"2654_CR75","doi-asserted-by":"publisher","unstructured":"Vanaja SK, Rathinam VA, Fitzgerald KA (2015) Mechanisms of inflammasome activation: recent advances and novel insights. Trends Cell Biol 25(5):308\u2013315.\u00a0https:\/\/doi.org\/10.1016\/j.tcb.2014.12.009","DOI":"10.1016\/j.tcb.2014.12.009"},{"key":"2654_CR76","doi-asserted-by":"publisher","unstructured":"Kantola IM (2019) Renal involvement in Fabry disease. Nephrol Dial Transplant 34(9):1435\u20131437.\u00a0https:\/\/doi.org\/10.1093\/ndt\/gfy412","DOI":"10.1093\/ndt\/gfy412"},{"key":"2654_CR77","doi-asserted-by":"publisher","unstructured":"Liebau MC, Braun F, Hopker K, Weitbrecht C, Bartels V, Muller RU, Brodesser S, Saleem MA, Benzing T, Schermer B, Cybulla M, Kurschat CE (2013) Dysregulated autophagy contributes to podocyte damage in Fabry\u2019s disease. PLoS One 8(5):e63506.\u00a0https:\/\/doi.org\/10.1371\/journal.pone.0063506","DOI":"10.1371\/journal.pone.0063506"},{"key":"2654_CR78","doi-asserted-by":"publisher","unstructured":"Waldek S, Feriozzi S (2014) Fabry nephropathy: a review - how can we optimize the management of Fabry nephropathy? BMC Nephrol 15:72.\u00a0https:\/\/doi.org\/10.1186\/1471-2369-15-72","DOI":"10.1186\/1471-2369-15-72"},{"key":"2654_CR79","doi-asserted-by":"publisher","unstructured":"Sanchez-Nino MD, Carpio D, Sanz AB, Ruiz-Ortega M, Mezzano S, Ortiz A (2015) Lyso-Gb3 activates Notch1 in human podocytes. Hum Mol Genet 24(20):5720\u20135732.\u00a0https:\/\/doi.org\/10.1093\/hmg\/ddv291","DOI":"10.1093\/hmg\/ddv291"},{"key":"2654_CR80","doi-asserted-by":"publisher","unstructured":"Germain DP, Charrow J, Desnick RJ, Guffon N, Kempf J, Lachmann RH, Lemay R, Linthorst GE, Packman S, Scott CR, Waldek S, Warnock DG, Weinreb NJ, Wilcox WR (2015) Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease. J Med Genet 52(5):353\u2013358. https:\/\/doi.org\/10.1136\/jmedgenet-2014-102797","DOI":"10.1136\/jmedgenet-2014-102797"},{"key":"2654_CR81","doi-asserted-by":"publisher","unstructured":"Rosenmann E, Aviram A (1973) Glomerular involvement in storage diseases. J Pathol 111(1):61\u201364.\u00a0https:\/\/doi.org\/10.1002\/path.1711110111","DOI":"10.1002\/path.1711110111"},{"key":"2654_CR82","doi-asserted-by":"publisher","unstructured":"Kuemmel TA, Thiele J, Schroeder R, Stoffel W (1997) Pathology of visceral organs and bone marrow in an acid sphingomyelinase deficient knock-out mouse line, mimicking human Niemann-Pick disease type A. A light and electron microscopic study. Pathol Res Pract 193(10):663\u2013671.\u00a0https:\/\/doi.org\/10.1016\/S0344-0338(97)80025-8","DOI":"10.1016\/S0344-0338(97)80025-8"},{"key":"2654_CR83","doi-asserted-by":"publisher","unstructured":"Guan L, Jia Z, Xu K, Yang M, Li X, Qiao L, Liu Y, Lin J (2024) Npc1 gene mutation abnormally activates the classical Wnt signalling pathway in mouse kidneys and promotes renal fibrosis. Anim Genet 55(1):99\u2013109.\u00a0https:\/\/doi.org\/10.1111\/age.13381","DOI":"10.1111\/age.13381"},{"key":"2654_CR84","unstructured":"Chander PN, Nurse HM, Pirani CL (1979) Renal involvement in adult Gaucher\u2019s disease after splenectomy. Arch Pathol Lab Med 103(9):440\u2013445"},{"key":"2654_CR85","doi-asserted-by":"publisher","unstructured":"Samuelsson K, Zetterstrom R (1971) Ceramides in a patient with lipogranulomatosis (Farber\u2019s disease) with chronic course. Scand J Clin Lab Invest 27(4):393\u2013405.\u00a0https:\/\/doi.org\/10.3109\/00365517109080235","DOI":"10.3109\/00365517109080235"},{"key":"2654_CR86","doi-asserted-by":"publisher","unstructured":"Li G, Kidd J, Kaspar C, Dempsey S, Bhat OM, Camus S, Ritter JK, Gehr TWB, Gulbins E, Li PL (2020) Podocytopathy and nephrotic syndrome in mice with podocyte-specific deletion of the Asah1 gene: role of ceramide accumulation in glomeruli. Am J Pathol 190(6):1211\u20131223.\u00a0https:\/\/doi.org\/10.1016\/j.ajpath.2020.02.008","DOI":"10.1016\/j.ajpath.2020.02.008"},{"key":"2654_CR87","doi-asserted-by":"publisher","unstructured":"Renwick N, Nasr SH, Chung WK, Garvin J, Markowitz GS, Marboe C, Thaker HM, D\u2019Agati VD (2003) Foamy podocytes. Am J Kidney Dis 41(4):891\u2013896.\u00a0https:\/\/doi.org\/10.1016\/s0272-6386(03)00133-1","DOI":"10.1016\/s0272-6386(03)00133-1"},{"key":"2654_CR88","doi-asserted-by":"publisher","unstructured":"Kobayashi H, Takahashi-Fujigasaki J, Fukuda T, Sakurai K, Shimada Y, Nomura K, Ariga M, Ohashi T, Eto Y, Otomo T, Sakai N, Ida H (2011) Pathology of the first autopsy case diagnosed as mucolipidosis type III alpha\/beta suggesting autophagic dysfunction. Mol Genet Metab 102(2):170\u2013175.\u00a0https:\/\/doi.org\/10.1016\/j.ymgme.2010.09.014","DOI":"10.1016\/j.ymgme.2010.09.014"},{"key":"2654_CR89","doi-asserted-by":"publisher","unstructured":"Zhao L, Li S, Gao Y (2021) Efficacy of statins on renal function in patients with chronic kidney disease: a systematic review and meta-analysis. Ren Fail 43(1):718\u2013728.\u00a0https:\/\/doi.org\/10.1080\/0886022X.2021.1915799","DOI":"10.1080\/0886022X.2021.1915799"},{"key":"2654_CR90","doi-asserted-by":"publisher","unstructured":"Chin HJ, Fu YY, Ahn JM, Na KY, Kim YS, Kim S, Chae DW (2010) Omacor, n-3 polyunsaturated fatty acid, attenuated albuminuria and renal dysfunction with decrease of SREBP-1 expression and triglyceride amount in the kidney of type II diabetic animals. Nephrol Dial Transplant 25(5):1450\u20131457.\u00a0https:\/\/doi.org\/10.1093\/ndt\/gfp695","DOI":"10.1093\/ndt\/gfp695"},{"key":"2654_CR91","doi-asserted-by":"publisher","unstructured":"Shapiro H, Theilla M, Attal-Singer J, Singer P (2011) Effects of polyunsaturated fatty acid consumption in diabetic nephropathy. Nat Rev Nephrol 7(2):110\u2013121.\u00a0https:\/\/doi.org\/10.1038\/nrneph.2010.156","DOI":"10.1038\/nrneph.2010.156"},{"key":"2654_CR92","doi-asserted-by":"publisher","unstructured":"Tanaka Y, Kume S, Araki S, Isshiki K, Chin-Kanasaki M, Sakaguchi M, Sugimoto T, Koya D, Haneda M, Kashiwagi A, Maegawa H, Uzu T (2011) Fenofibrate, a PPARalpha agonist, has renoprotective effects in mice by enhancing renal lipolysis. Kidney Int 79(8):871\u2013882.\u00a0https:\/\/doi.org\/10.1038\/ki.2010.530","DOI":"10.1038\/ki.2010.530"},{"key":"2654_CR93","doi-asserted-by":"publisher","unstructured":"Ren H, Shao Y, Wu C, Ma X, Lv C, Wang Q (2020) Metformin alleviates oxidative stress and enhances autophagy in diabetic kidney disease via AMPK\/SIRT1-FoxO1 pathway. Mol Cell Endocrinol 500:110628.\u00a0https:\/\/doi.org\/10.1016\/j.mce.2019.110628","DOI":"10.1016\/j.mce.2019.110628"},{"key":"2654_CR94","doi-asserted-by":"publisher","unstructured":"Liu X, Xu C, Xu L, Li X, Sun H, Xue M, Li T, Yu X, Sun B, Chen L (2020) Empagliflozin improves diabetic renal tubular injury by alleviating mitochondrial fission via AMPK\/SP1\/PGAM5 pathway. Metabolism 111:154334.\u00a0https:\/\/doi.org\/10.1016\/j.metabol.2020.154334","DOI":"10.1016\/j.metabol.2020.154334"},{"key":"2654_CR95","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.83353","author":"M Ge","year":"2023","unstructured":"Ge M, Molina J, Kim JJ, Mallela SK, Ahmad A, Varona Santos J, Al-Ali H, Mitrofanova A, Sharma K, Fontanesi F, Merscher S, Fornoni A (2023) Empagliflozin reduces podocyte lipotoxicity in experimental Alport syndrome. Elife. https:\/\/doi.org\/10.7554\/eLife.83353","journal-title":"Elife"},{"key":"2654_CR96","doi-asserted-by":"publisher","unstructured":"Wang C, Li L, Liu S, Liao G, Li L, Chen Y, Cheng J, Lu Y, Liu J (2018) GLP-1 receptor agonist ameliorates obesity-induced chronic kidney injury via restoring renal metabolism homeostasis. PLoS One 13(3):e0193473.\u00a0https:\/\/doi.org\/10.1371\/journal.pone.0193473","DOI":"10.1371\/journal.pone.0193473"},{"key":"2654_CR97","doi-asserted-by":"publisher","unstructured":"Shen R, Qin S, Lv Y, Liu D, Ke Q, Shi C, Jiang L, Yang J, Zhou Y (2024) GLP-1 receptor agonist attenuates tubular cell ferroptosis in diabetes via enhancing AMPK-fatty acid metabolism pathway through macropinocytosis. Biochim Biophys Acta Mol Basis Dis 1870(4):167060.\u00a0https:\/\/doi.org\/10.1016\/j.bbadis.2024.167060","DOI":"10.1016\/j.bbadis.2024.167060"},{"key":"2654_CR98","doi-asserted-by":"publisher","unstructured":"Dorotea D, Cho A, Lee G, Kwon G, Lee J, Sahu PK, Jeong LS, Cha DR, Ha H (2018) Orally active, species-independent novel A(3) adenosine receptor antagonist protects against kidney injury in db\/db mice. Exp Mol Med 50(4):1\u201314.\u00a0https:\/\/doi.org\/10.1038\/s12276-018-0053-x","DOI":"10.1038\/s12276-018-0053-x"},{"issue":"7","key":"2654_CR99","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-021-01816-0","volume":"17","author":"KM Sas","year":"2021","unstructured":"Sas KM, Lin J, Wang CH, Zhang H, Saha J, Rajendiran TM, Soni T, Nair V, Eichinger F, Kretzler M, Brosius FC 3rd, Michailidis G, Pennathur S (2021) Renin-angiotensin system inhibition reverses the altered triacylglycerol metabolic network in diabetic kidney disease. Metabolomics 17(7):65. https:\/\/doi.org\/10.1007\/s11306-021-01816-0","journal-title":"Metabolomics"},{"key":"2654_CR100","doi-asserted-by":"publisher","unstructured":"Naito S, Kamata M, Furuya M, Hayashi M, Kuroda M, Bujo H, Kamata K (2013) Amelioration of circulating lipoprotein profile and proteinuria in a patient with LCAT deficiency due to a novel mutation (Cys74Tyr) in the lid region of LCAT under a fat-restricted diet and ARB treatment. Atherosclerosis 228(1):193\u2013197.\u00a0https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.02.034","DOI":"10.1016\/j.atherosclerosis.2013.02.034"},{"key":"2654_CR101","doi-asserted-by":"publisher","unstructured":"Wang XX, Wang D, Luo Y, Myakala K, Dobrinskikh E, Rosenberg AZ, Levi J, Kopp JB, Field A, Hill A, Lucia S, Qiu L, Jiang T, Peng Y, Orlicky D, Garcia G, Herman-Edelstein M, D\u2019Agati V, Henriksen K, Adorini L, Pruzanski M, Xie C, Krausz KW, Gonzalez FJ, Ranjit S, Dvornikov A, Gratton E, Levi M (2018) FXR\/TGR5 dual agonist prevents progression of nephropathy in diabetes and obesity. J Am Soc Nephrol 29(1):118\u2013137.\u00a0https:\/\/doi.org\/10.1681\/ASN.2017020222","DOI":"10.1681\/ASN.2017020222"},{"key":"2654_CR102","doi-asserted-by":"publisher","unstructured":"Yamamoto T, Takabatake Y, Takahashi A, Kimura T, Namba T, Matsuda J, Minami S, Kaimori JY, Matsui I, Matsusaka T, Niimura F, Yanagita M, Isaka Y (2017) High-fat diet-induced lysosomal dysfunction and impaired autophagic flux contribute to lipotoxicity in the kidney. J Am Soc Nephrol 28(5):1534\u20131551.\u00a0https:\/\/doi.org\/10.1681\/ASN.2016070731","DOI":"10.1681\/ASN.2016070731"},{"key":"2654_CR103","doi-asserted-by":"publisher","unstructured":"Nakamura S, Shigeyama S, Minami S, Shima T, Akayama S, Matsuda T, Esposito A, Napolitano G, Kuma A, Namba-Hamano T, Nakamura J, Yamamoto K, Sasai M, Tokumura A, Miyamoto M, Oe Y, Fujita T, Terawaki S, Takahashi A, Hamasaki M, Yamamoto M, Okada Y, Komatsu M, Nagai T, Takabatake Y, Xu H, Isaka Y, Ballabio A, Yoshimori T (2020) LC3 lipidation is essential for TFEB activation during the lysosomal damage response to kidney injury. Nat Cell Biol 22(10):1252\u20131263. https:\/\/doi.org\/10.1038\/s41556-020-00583-9","DOI":"10.1038\/s41556-020-00583-9"},{"key":"2654_CR104","doi-asserted-by":"publisher","unstructured":"Chen Y, Deb DK, Fu X, Yi B, Liang Y, Du J, He L, Li YC (2019) ATP-citrate lyase is an epigenetic regulator to promote obesity-related kidney injury. FASEB J 33(8):9602\u20139615.\u00a0https:\/\/doi.org\/10.1096\/fj.201900213R","DOI":"10.1096\/fj.201900213R"},{"key":"2654_CR105","doi-asserted-by":"publisher","unstructured":"Liu BC, Tang TT, Lv LL, Lan HY (2018) Renal tubule injury: a driving force toward chronic kidney disease. Kidney Int 93(3):568\u2013579.\u00a0https:\/\/doi.org\/10.1016\/j.kint.2017.09.033","DOI":"10.1016\/j.kint.2017.09.033"},{"key":"2654_CR106","doi-asserted-by":"publisher","unstructured":"Lee S, Huen S, Nishio H, Nishio S, Lee HK, Choi BS, Ruhrberg C, Cantley LG (2011) Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol 22(2):317\u2013326.\u00a0https:\/\/doi.org\/10.1681\/ASN.2009060615","DOI":"10.1681\/ASN.2009060615"},{"issue":"1","key":"2654_CR107","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-022-02794-8","volume":"23","author":"A Hofherr","year":"2022","unstructured":"Hofherr A, Williams J, Gan LM, Soderberg M, Hansen PBL, Woollard KJ (2022) Targeting inflammation for the treatment of diabetic kidney disease: a five-compartment mechanistic model. BMC Nephrol 23(1):208. https:\/\/doi.org\/10.1186\/s12882-022-02794-8","journal-title":"BMC Nephrol"},{"key":"2654_CR108","doi-asserted-by":"publisher","unstructured":"Sato Y, Yanagita M (2018) Immune cells and inflammation in AKI to CKD progression. Am J Physiol Renal Physiol 315(6):F1501\u2013F1512.\u00a0https:\/\/doi.org\/10.1152\/ajprenal.00195.2018","DOI":"10.1152\/ajprenal.00195.2018"},{"key":"2654_CR109","doi-asserted-by":"publisher","unstructured":"Lan HY (2011) Diverse roles of TGF-beta\/Smads in renal fibrosis and inflammation. Int J Biol Sci 7(7):1056\u20131067.\u00a0https:\/\/doi.org\/10.7150\/ijbs.7.1056","DOI":"10.7150\/ijbs.7.1056"},{"key":"2654_CR110","doi-asserted-by":"publisher","unstructured":"Kim JE, Lee MH, Nam DH, Song HK, Kang YS, Lee JE, Kim HW, Cha JJ, Hyun YY, Han SY, Han KH, Han JY, Cha DR (2013) Celastrol, an NF-kappaB inhibitor, improves insulin resistance and attenuates renal injury in db\/db mice. PLoS One 8(4):e62068.\u00a0https:\/\/doi.org\/10.1371\/journal.pone.0062068","DOI":"10.1371\/journal.pone.0062068"},{"key":"2654_CR111","doi-asserted-by":"publisher","unstructured":"Sun D, Chen J, Wu W, Tang J, Luo L, Zhang K, Jin L, Lin S, Gao Y, Yan X, Zhang C (2019) MiR-802 causes nephropathy by suppressing NF-kappaB-repressing factor in obese mice and human. J Cell Mol Med 23(4):2863\u20132871.\u00a0https:\/\/doi.org\/10.1111\/jcmm.14193","DOI":"10.1111\/jcmm.14193"},{"key":"2654_CR112","doi-asserted-by":"publisher","unstructured":"Liu E, Lv L, Zhan Y, Ma Y, Feng J, He Y, Wen Y, Zhang Y, Pu Q, Ji F, Yang X, Wen JG (2021) METTL3\/N6-methyladenosine\/ miR-21-5p promotes obstructive renal fibrosis by regulating inflammation through SPRY1\/ERK\/NF-kappaB pathway activation. J Cell Mol Med 25(16):7660\u20137674.\u00a0https:\/\/doi.org\/10.1111\/jcmm.16603","DOI":"10.1111\/jcmm.16603"},{"issue":"4","key":"2654_CR113","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.kint.2017.03.027","volume":"92","author":"H Zhang","year":"2017","unstructured":"Zhang H, Nair V, Saha J, Atkins KB, Hodgin JB, Saunders TL, Myers MG Jr., Werner T, Kretzler M, Brosius FC (2017) Podocyte-specific JAK2 overexpression worsens diabetic kidney disease in mice. Kidney Int 92(4):909\u2013921. https:\/\/doi.org\/10.1016\/j.kint.2017.03.027","journal-title":"Kidney Int"},{"key":"2654_CR114","doi-asserted-by":"publisher","unstructured":"Chen W, Yuan H, Cao W, Wang T, Chen W, Yu H, Fu Y, Jiang B, Zhou H, Guo H, Zhao X (2019) Blocking interleukin-6 trans-signaling protects against renal fibrosis by suppressing STAT3 activation. Theranostics 9(14):3980\u20133991.\u00a0https:\/\/doi.org\/10.7150\/thno.32352","DOI":"10.7150\/thno.32352"},{"key":"2654_CR115","doi-asserted-by":"publisher","unstructured":"Tao J, Mariani L, Eddy S, Maecker H, Kambham N, Mehta K, Hartman J, Wang W, Kretzler M, Lafayette RA (2018) JAK-STAT signaling is activated in the kidney and peripheral blood cells of patients with focal segmental glomerulosclerosis. Kidney Int 94(4):795\u2013808.\u00a0https:\/\/doi.org\/10.1016\/j.kint.2018.05.022","DOI":"10.1016\/j.kint.2018.05.022"},{"key":"2654_CR116","doi-asserted-by":"publisher","unstructured":"Tao J, Mariani L, Eddy S, Maecker H, Kambham N, Mehta K, Hartman J, Wang W, Kretzler M, Lafayette RA (2020) Jak-STAT activity in peripheral blood cells and kidney tissue in IgA nephropathy. Clin J Am Soc Nephrol 15(7):973\u2013982.\u00a0https:\/\/doi.org\/10.2215\/CJN.11010919","DOI":"10.2215\/CJN.11010919"},{"key":"2654_CR117","doi-asserted-by":"publisher","unstructured":"Tang SCW, Yiu WH (2020) Innate immunity in diabetic kidney disease. Nat Rev Nephrol 16(4):206\u2013222.\u00a0https:\/\/doi.org\/10.1038\/s41581-019-0234-4","DOI":"10.1038\/s41581-019-0234-4"},{"key":"2654_CR118","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.137191","author":"R Upadhyay","year":"2020","unstructured":"Upadhyay R, Ying WZ, Nasrin Z, Safah H, Jaimes EA, Feng W, Sanders PW, Batuman V (2020) Free light chains injure proximal tubule cells through the STAT1\/HMGB1\/TLR axis. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.137191","journal-title":"JCI Insight"},{"key":"2654_CR119","doi-asserted-by":"publisher","unstructured":"Komada T, Muruve DA (2019) The role of inflammasomes in kidney disease. Nat Rev Nephrol 15(8):501\u2013520.\u00a0https:\/\/doi.org\/10.1038\/s41581-019-0158-z","DOI":"10.1038\/s41581-019-0158-z"},{"key":"2654_CR120","doi-asserted-by":"publisher","unstructured":"Bakker PJ, Butter LM, Kors L, Teske GJ, Aten J, Sutterwala FS, Florquin S, Leemans JC (2014) Nlrp3 is a key modulator of diet-induced nephropathy and renal cholesterol accumulation. Kidney Int 85(5):1112\u20131122.\u00a0https:\/\/doi.org\/10.1038\/ki.2013.503","DOI":"10.1038\/ki.2013.503"},{"issue":"1","key":"2654_CR121","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41392-022-01036-5","volume":"7","author":"Q Yuan","year":"2022","unstructured":"Yuan Q, Tang B, Zhang C (2022) Signaling pathways of chronic kidney diseases, implications for therapeutics. Signal Transduct Target Ther 7(1):182. https:\/\/doi.org\/10.1038\/s41392-022-01036-5","journal-title":"Signal Transduct Target Ther"},{"key":"2654_CR122","doi-asserted-by":"publisher","unstructured":"Jha JC, Thallas-Bonke V, Banal C, Gray SP, Chow BS, Ramm G, Quaggin SE, Cooper ME, Schmidt HH, Jandeleit-Dahm KA (2016) Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy. Diabetologia 59(2):379\u2013389.\u00a0https:\/\/doi.org\/10.1007\/s00125-015-3796-0","DOI":"10.1007\/s00125-015-3796-0"},{"key":"2654_CR123","doi-asserted-by":"publisher","unstructured":"Zhou L, Chen X, Lu M, Wu Q, Yuan Q, Hu C, Miao J, Zhang Y, Li H, Hou FF, Nie J, Liu Y (2019) Wnt\/beta-catenin links oxidative stress to podocyte injury and proteinuria. Kidney Int 95(4):830\u2013845.\u00a0https:\/\/doi.org\/10.1016\/j.kint.2018.10.032","DOI":"10.1016\/j.kint.2018.10.032"},{"key":"2654_CR124","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-025-00938-1","author":"JH Byun","year":"2025","unstructured":"Byun JH, Lebeau PF, Trink J, Uppal N, Lanktree MB, Krepinsky JC, Austin RC (2025) Endoplasmic reticulum stress as a driver and therapeutic target for kidney disease. Nat Rev Nephrol. https:\/\/doi.org\/10.1038\/s41581-025-00938-1","journal-title":"Nat Rev Nephrol"},{"key":"2654_CR125","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031518","author":"LY Chang","year":"2024","unstructured":"Chang LY, Chao YL, Chiu CC, Chen PL, Lin HY (2024) Mitochondrial signaling, the mechanisms of AKI-to-CKD transition and potential treatment targets. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25031518","journal-title":"Int J Mol Sci"},{"key":"2654_CR126","doi-asserted-by":"publisher","unstructured":"Qin X, Zhao Y, Gong J, Huang W, Su H, Yuan F, Fang K, Wang D, Li J, Zou X, Xu L, Dong H, Lu F (2019) Berberine protects glomerular podocytes via inhibiting Drp1-mediated mitochondrial fission and dysfunction. Theranostics 9(6):1698\u20131713.\u00a0https:\/\/doi.org\/10.7150\/thno.30640","DOI":"10.7150\/thno.30640"},{"key":"2654_CR127","doi-asserted-by":"publisher","DOI":"10.3390\/cells9020338","author":"Y Wang","year":"2020","unstructured":"Wang Y, Cai J, Tang C, Dong Z (2020) Mitophagy in acute kidney injury and kidney repair. Cells. https:\/\/doi.org\/10.3390\/cells9020338","journal-title":"Cells"},{"key":"2654_CR128","doi-asserted-by":"publisher","unstructured":"Liu L, Li Y, Chen G, Chen Q (2023) Crosstalk between mitochondrial biogenesis and mitophagy to maintain mitochondrial homeostasis. J Biomed Sci 30(1):86.\u00a0https:\/\/doi.org\/10.1186\/s12929-023-00975-7","DOI":"10.1186\/s12929-023-00975-7"},{"key":"2654_CR129","doi-asserted-by":"publisher","unstructured":"Tran M, Tam D, Bardia A, Bhasin M, Rowe GC, Kher A, Zsengeller ZK, Akhavan-Sharif MR, Khankin EV, Saintgeniez M, David S, Burstein D, Karumanchi SA, Stillman IE, Arany Z, Parikh SM (2011) PGC-1alpha promotes recovery after acute kidney injury during systemic inflammation in mice. J Clin Invest 121(10):4003\u20134014.\u00a0https:\/\/doi.org\/10.1172\/JCI58662","DOI":"10.1172\/JCI58662"},{"key":"2654_CR130","doi-asserted-by":"publisher","unstructured":"Svensson K, Schnyder S, Cardel B, Handschin C (2016) Loss of renal tubular PGC-1alpha exacerbates diet-induced renal steatosis and age-related urinary sodium excretion in mice. PLoS One 11(7):e0158716.\u00a0https:\/\/doi.org\/10.1371\/journal.pone.0158716","DOI":"10.1371\/journal.pone.0158716"},{"key":"2654_CR131","doi-asserted-by":"publisher","unstructured":"Tran MT, Zsengeller ZK, Berg AH, Khankin EV, Bhasin MK, Kim W, Clish CB, Stillman IE, Karumanchi SA, Rhee EP, Parikh SM (2016) PGC1alpha drives NAD biosynthesis linking oxidative metabolism to renal protection. Nature 531(7595):528\u2013532.\u00a0https:\/\/doi.org\/10.1038\/nature17184","DOI":"10.1038\/nature17184"},{"key":"2654_CR132","doi-asserted-by":"publisher","unstructured":"Fontecha-Barriuso M, Martin-Sanchez D, Martinez-Moreno JM, Carrasco S, Ruiz-Andres O, Monsalve M, Sanchez-Ramos C, Gomez MJ, Ruiz-Ortega M, Sanchez-Nino MD, Cannata-Ortiz P, Cabello R, Gonzalez-Enguita C, Ortiz A, Sanz AB (2019) PGC-1alpha deficiency causes spontaneous kidney inflammation and increases the severity of nephrotoxic AKI. J Pathol 249(1):65\u201378.\u00a0https:\/\/doi.org\/10.1002\/path.5282","DOI":"10.1002\/path.5282"},{"key":"2654_CR133","doi-asserted-by":"publisher","unstructured":"Livingston MJ, Wang J, Zhou J, Wu G, Ganley IG, Hill JA, Yin XM, Dong Z (2019) Clearance of damaged mitochondria via mitophagy is important to the protective effect of ischemic preconditioning in kidneys. Autophagy 15(12):2142\u20132162.https:\/\/doi.org\/10.1080\/15548627.2019.1615822","DOI":"10.1080\/15548627.2019.1615822"},{"key":"2654_CR134","doi-asserted-by":"publisher","unstructured":"Mizuno M, Blanchin S, Gasque P, Nishikawa K, Matsuo S (2007) High levels of complement C3a receptor in the glomeruli in lupus nephritis. Am J Kidney Dis 49(5):598\u2013606.\u00a0https:\/\/doi.org\/10.1053\/j.ajkd.2007.02.271","DOI":"10.1053\/j.ajkd.2007.02.271"},{"key":"2654_CR135","doi-asserted-by":"publisher","unstructured":"Liu L, Zhang Y, Duan X, Peng Q, Liu Q, Zhou Y, Quan S, Xing G (2014) C3a, C5a renal expression and their receptors are correlated to severity of IgA nephropathy. J Clin Immunol 34(2):224\u2013232.\u00a0https:\/\/doi.org\/10.1007\/s10875-013-9970-6","DOI":"10.1007\/s10875-013-9970-6"},{"key":"2654_CR136","doi-asserted-by":"publisher","unstructured":"Li L, Chen L, Zang J, Tang X, Liu Y, Zhang J, Bai L, Yin Q, Lu Y, Cheng J, Fu P, Liu F (2015) C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt\/beta-catenin signaling pathway in diabetic kidney disease. Metabolism 64(5):597\u2013610.\u00a0https:\/\/doi.org\/10.1016\/j.metabol.2015.01.014","DOI":"10.1016\/j.metabol.2015.01.014"},{"key":"2654_CR137","doi-asserted-by":"publisher","unstructured":"Buelli S, Imberti B, Morigi M (2024) The complement C3a and C5a signaling in renal diseases: a bridge between acute and chronic inflammation. Nephron 148(10):712\u2013723.\u00a0https:\/\/doi.org\/10.1159\/000538241","DOI":"10.1159\/000538241"},{"issue":"5","key":"2654_CR138","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1681\/ASN.2006121343","volume":"18","author":"P Boor","year":"2007","unstructured":"Boor P, Konieczny A, Villa L, Schult AL, Bucher E, Rong S, Kunter U, van Roeyen CR, Polakowski T, Hawlisch H, Hillebrandt S, Lammert F, Eitner F, Floege J, Ostendorf T (2007) Complement C5 mediates experimental tubulointerstitial fibrosis. J Am Soc Nephrol 18(5):1508\u20131515. https:\/\/doi.org\/10.1681\/ASN.2006121343","journal-title":"J Am Soc Nephrol"},{"key":"2654_CR139","doi-asserted-by":"publisher","unstructured":"Yiu WH, Li RX, Wong DWL, Wu HJ, Chan KW, Chan LYY, Leung JCK, Lai KN, Sacks SH, Zhou W, Tang SCW (2018) Complement C5a inhibition moderates lipid metabolism and reduces tubulointerstitial fibrosis in diabetic nephropathy. Nephrol Dial Transplant 33(8):1323\u20131332.\u00a0https:\/\/doi.org\/10.1093\/ndt\/gfx336","DOI":"10.1093\/ndt\/gfx336"},{"key":"2654_CR140","doi-asserted-by":"publisher","unstructured":"Gong XJ, Huang J, Shu Y, Wang M, Ji J, Yang L, Zhao MH, Cui Z (2025) Complement C5a and C5a receptor 1 mediates glomerular damage in focal segmental glomerulosclerosis. Clin Immunol 273:110459.\u00a0https:\/\/doi.org\/10.1016\/j.clim.2025.110459","DOI":"10.1016\/j.clim.2025.110459"},{"key":"2654_CR141","doi-asserted-by":"publisher","unstructured":"Tang Z, Lu B, Hatch E, Sacks SH, Sheerin NS (2009) C3a mediates epithelial-to-mesenchymal transition in proteinuric nephropathy. J Am Soc Nephrol 20(3):593\u2013603.\u00a0https:\/\/doi.org\/10.1681\/ASN.2008040434","DOI":"10.1681\/ASN.2008040434"},{"key":"2654_CR142","doi-asserted-by":"publisher","unstructured":"Humphreys BD (2018) Mechanisms of renal fibrosis. Annu Rev Physiol 80:309\u2013326.\u00a0https:\/\/doi.org\/10.1146\/annurev-physiol-022516-034227","DOI":"10.1146\/annurev-physiol-022516-034227"},{"key":"2654_CR143","doi-asserted-by":"publisher","unstructured":"Li L, Fu H, Liu Y (2022) The fibrogenic niche in kidney fibrosis: components and mechanisms. Nat Rev Nephrol 18(9):545\u2013557. https:\/\/doi.org\/10.1038\/s41581-022-00590-z","DOI":"10.1038\/s41581-022-00590-z"},{"key":"2654_CR144","doi-asserted-by":"publisher","unstructured":"Fu H, Tian Y, Zhou L, Zhou D, Tan RJ, Stolz DB, Liu Y (2017) Tenascin-C is a major component of the fibrogenic niche in kidney fibrosis. J Am Soc Nephrol 28(3):785\u2013801.\u00a0https:\/\/doi.org\/10.1681\/ASN.2016020165","DOI":"10.1681\/ASN.2016020165"},{"key":"2654_CR145","doi-asserted-by":"publisher","unstructured":"Piek E, Ju WJ, Heyer J, Escalante-Alcalde D, Stewart CL, Weinstein M, Deng C, Kucherlapati R, Bottinger EP, Roberts AB (2001) Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts. J Biol Chem 276(23):19945\u201319953.\u00a0https:\/\/doi.org\/10.1074\/jbc.M102382200","DOI":"10.1074\/jbc.M102382200"},{"key":"2654_CR146","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2015.00082","volume":"6","author":"XM Meng","year":"2015","unstructured":"Meng XM, Tang PM, Li J, Lan HY (2015) TGF-beta\/Smad signaling in renal fibrosis. Front Physiol 6:82. https:\/\/doi.org\/10.3389\/fphys.2015.00082","journal-title":"Front Physiol"},{"key":"2654_CR147","doi-asserted-by":"publisher","unstructured":"Meng XM, Nikolic-Paterson DJ, Lan HY (2016) TGF-beta: the master regulator of fibrosis. Nat Rev Nephrol 12(6):325\u2013338.\u00a0https:\/\/doi.org\/10.1038\/nrneph.2016.48","DOI":"10.1038\/nrneph.2016.48"},{"key":"2654_CR148","doi-asserted-by":"publisher","unstructured":"Surendran K, Schiavi S, Hruska KA (2005) Wnt-dependent beta-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis. J Am Soc Nephrol 16(8):2373\u20132384.\u00a0https:\/\/doi.org\/10.1681\/ASN.2004110949","DOI":"10.1681\/ASN.2004110949"},{"key":"2654_CR149","doi-asserted-by":"publisher","unstructured":"Feng Y, Ren J, Gui Y, Wei W, Shu B, Lu Q, Xue X, Sun X, He W, Yang J, Dai C (2018) Wnt\/beta-catenin-promoted macrophage alternative activation contributes to kidney fibrosis. J Am Soc Nephrol 29(1):182\u2013193.\u00a0https:\/\/doi.org\/10.1681\/ASN.2017040391","DOI":"10.1681\/ASN.2017040391"},{"key":"2654_CR150","doi-asserted-by":"publisher","unstructured":"Akhmetshina A, Palumbo K, Dees C, Bergmann C, Venalis P, Zerr P, Horn A, Kireva T, Beyer C, Zwerina J, Schneider H, Sadowski A, Riener MO, MacDougald OA, Distler O, Schett G, Distler JH (2012) Activation of canonical Wnt signalling is required for TGF-beta-mediated fibrosis. Nat Commun 3:735.\u00a0https:\/\/doi.org\/10.1038\/ncomms1734","DOI":"10.1038\/ncomms1734"},{"key":"2654_CR151","doi-asserted-by":"publisher","unstructured":"Edeling M, Ragi G, Huang S, Pavenstadt H, Susztak K (2016) Developmental signalling pathways in renal fibrosis: the roles of Notch, Wnt and Hedgehog. Nat Rev Nephrol 12(7):426\u2013439.\u00a0https:\/\/doi.org\/10.1038\/nrneph.2016.54","DOI":"10.1038\/nrneph.2016.54"},{"key":"2654_CR152","doi-asserted-by":"publisher","unstructured":"Lin CL, Wang FS, Hsu YC, Chen CN, Tseng MJ, Saleem MA, Chang PJ, Wang JY (2010) Modulation of notch-1 signaling alleviates vascular endothelial growth factor-mediated diabetic nephropathy. Diabetes 59(8):1915\u20131925.\u00a0https:\/\/doi.org\/10.2337\/db09-0663","DOI":"10.2337\/db09-0663"},{"key":"2654_CR153","doi-asserted-by":"publisher","unstructured":"Li L, Liu Q, Shang T, Song W, Xu D, Allen TD, Wang X, Jeong J, Lobe CG, Liu J (2021) Aberrant activation of Notch1 signaling in glomerular endothelium induces albuminuria. Circ Res 128(5):602\u2013618.\u00a0https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.316970","DOI":"10.1161\/CIRCRESAHA.120.316970"},{"key":"2654_CR154","doi-asserted-by":"publisher","unstructured":"Macconi D, Remuzzi G, Benigni A (2014) Key fibrogenic mediators: old players. Renin-angiotensin system. Kidney Int Suppl 4(1):58\u201364.\u00a0https:\/\/doi.org\/10.1038\/kisup.2014.11","DOI":"10.1038\/kisup.2014.11"},{"key":"2654_CR155","doi-asserted-by":"publisher","unstructured":"AlQudah M, Hale TM, Czubryt MP (2020) Targeting the renin-angiotensin-aldosterone system in fibrosis. Matrix Biol 91:92\u2013108.\u00a0https:\/\/doi.org\/10.1016\/j.matbio.2020.04.005","DOI":"10.1016\/j.matbio.2020.04.005"},{"key":"2654_CR156","doi-asserted-by":"publisher","unstructured":"Sanglard A, Castello Branco Miranda B, Franca Vieira AL, Miranda Macedo MV, Lara Santos R, Stenner Rodrigues Radicchi Campos A, Campos Piva A and Simoes ESAC (2025). The role of renin-angiotensin system in diabetic nephropathy: an update. Mini Rev Med Chem https:\/\/doi.org\/10.2174\/0113895575344980250130062547.","DOI":"10.2174\/0113895575344980250130062547"},{"key":"2654_CR157","doi-asserted-by":"publisher","unstructured":"Ding W, Yang L, Zhang M, Gu Y (2012) Chronic inhibition of nuclear factor kappa B attenuates aldosterone\/salt-induced renal injury. Life Sci 90(15\u201316):600\u2013606.\u00a0https:\/\/doi.org\/10.1016\/j.lfs.2012.02.022","DOI":"10.1016\/j.lfs.2012.02.022"},{"key":"2654_CR158","doi-asserted-by":"publisher","unstructured":"Manotham K, Tanaka T, Matsumoto M, Ohse T, Inagi R, Miyata T, Kurokawa K, Fujita T, Ingelfinger JR, Nangaku M (2004) Transdifferentiation of cultured tubular cells induced by hypoxia. Kidney Int 65(3):871\u2013880. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00461.x","DOI":"10.1111\/j.1523-1755.2004.00461.x"},{"key":"2654_CR159","doi-asserted-by":"publisher","unstructured":"Tanaka T, Nangaku M (2010) The role of hypoxia, increased oxygen consumption, and hypoxia-inducible factor-1 alpha in progression of chronic kidney disease. Curr Opin Nephrol Hypertens 19(1):43\u201350.\u00a0https:\/\/doi.org\/10.1097\/MNH.0b013e3283328eed","DOI":"10.1097\/MNH.0b013e3283328eed"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-026-02654-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-026-02654-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-026-02654-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T01:33:29Z","timestamp":1771551209000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-026-02654-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":159,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2654"],"URL":"https:\/\/doi.org\/10.1007\/s00109-026-02654-0","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"46"}}